Menu
Back to Journals » OncoTargets and Therapy » Volume 13
Antitumor Activity of Larotrectinib in Tumors Harboring NTRK Gene Fusions: A Short Review on the Current Evidence [Corrigendum]
Authors Ricciuti B, Genova C , Crinò L , Libra M, Leonardi GC
Received 17 February 2020
Accepted for publication 17 February 2020
Published 11 May 2020 Volume 2020:13 Pages 3975—3976
Ricciuti B, Genova C, Crinò L, Libra M, Leonardi GC. Onco Targets Ther. 2019;12:3171–3179.
Lucio Crinò has advised that affiliation 3 is incorrect. The correct affiliation 3 should be as follows:
Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST IRCCS), Meldola, Italy.
Read the original article
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.